Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in Asian population
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sang-Ho | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Choi, Byoung-Geol | - |
dc.contributor.author | Park, Ji-Young | - |
dc.contributor.author | Jeon, Ung | - |
dc.contributor.author | Seo, Hong-Seog | - |
dc.contributor.author | Kim, Eung-Ju | - |
dc.contributor.author | Na, Jin-Oh | - |
dc.contributor.author | Choi, Cheol-Ung | - |
dc.contributor.author | Kim, Jin-Won | - |
dc.contributor.author | Lim, Hong-Euy | - |
dc.contributor.author | Park, Chang-Gyu | - |
dc.contributor.author | Oh, Dong-Joo | - |
dc.date.accessioned | 2021-09-04T15:46:34Z | - |
dc.date.available | 2021-09-04T15:46:34Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2015-06 | - |
dc.identifier.issn | 0305-1870 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93435 | - |
dc.description.abstract | Lipoprotein(a) (Lp(a)) is known to be associated with cardiovascular complications and atherothrombotic properties in general populations. However, it has not been examined whether Lp(a) levels are able to predict adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES). A total of 595 consecutive patients with angina pectoris who underwent elective PCI with DES were enrolled from 2004 to 2010. The patients were divided into two groups according to the levels of Lp(a): Lp(a) <50mg/dL (n=485 patients), and Lp(a) 50mg/dL (n=111 patients). The 6-9-month angiographic outcomes and 3-year cumulative major clinical outcomes were compared between the two groups. Binary restenosis occurred in 26 of 133 lesions (19.8%) in the high Lp(a) group and 43 of 550 lesions (7.9%) in the low Lp(a) group (P=0.001). In multivariate analysis, the reference vessel diameter, low density lipoprotein cholesterol, total lesion length, and Lp(a) 50mg/dL were predictors of binary restenosis. In the Cox proportional hazards regression analysis, Lp(a) >50mg/dL was significantly associated with the 3-year adverse clinical outcomes including any myocardial infarction, revascularization (target lesion revascularization (TLR) and target vessel revascularization (TVR)), TLR-major adverse cardiac events (MACEs), TVR-MACE, and All-MACEs. In our study, high Lp(a) level 50mg/dL in angina pectoris patients undergoing elective PCI with DES was significantly associated with binary restenosis and 3-year adverse clinical outcomes in an Asian population. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.subject | C-REACTIVE PROTEIN | - |
dc.subject | PLASMA LIPOPROTEIN(A) | - |
dc.subject | CARDIOVASCULAR RISK | - |
dc.subject | SERUM LIPOPROTEIN(A) | - |
dc.subject | LDL CHOLESTEROL | - |
dc.subject | DISEASE | - |
dc.subject | IMPLANTATION | - |
dc.subject | ANGIOPLASTY | - |
dc.subject | CELLS | - |
dc.subject | HEART | - |
dc.title | Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in Asian population | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rha, Seung-Woon | - |
dc.contributor.affiliatedAuthor | Seo, Hong-Seog | - |
dc.contributor.affiliatedAuthor | Kim, Eung-Ju | - |
dc.contributor.affiliatedAuthor | Na, Jin-Oh | - |
dc.contributor.affiliatedAuthor | Choi, Cheol-Ung | - |
dc.contributor.affiliatedAuthor | Lim, Hong-Euy | - |
dc.contributor.affiliatedAuthor | Park, Chang-Gyu | - |
dc.contributor.affiliatedAuthor | Oh, Dong-Joo | - |
dc.identifier.doi | 10.1111/1440-1681.12396 | - |
dc.identifier.scopusid | 2-s2.0-84930337711 | - |
dc.identifier.wosid | 000355878500005 | - |
dc.identifier.bibliographicCitation | CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, v.42, no.6, pp.588 - 595 | - |
dc.relation.isPartOf | CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | - |
dc.citation.title | CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | - |
dc.citation.volume | 42 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 588 | - |
dc.citation.endPage | 595 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Physiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Physiology | - |
dc.subject.keywordPlus | C-REACTIVE PROTEIN | - |
dc.subject.keywordPlus | PLASMA LIPOPROTEIN(A) | - |
dc.subject.keywordPlus | CARDIOVASCULAR RISK | - |
dc.subject.keywordPlus | SERUM LIPOPROTEIN(A) | - |
dc.subject.keywordPlus | LDL CHOLESTEROL | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | IMPLANTATION | - |
dc.subject.keywordPlus | ANGIOPLASTY | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | HEART | - |
dc.subject.keywordAuthor | angina | - |
dc.subject.keywordAuthor | coronary | - |
dc.subject.keywordAuthor | lipoprotein(a) | - |
dc.subject.keywordAuthor | restenosis | - |
dc.subject.keywordAuthor | stents | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.